American College of Clinical Pharmacy
      Search      Cart
         

Guidance on the Guidelines: Recent Therapeutic Updates

Saturday, October 26, 2019 from 9:45 AM to 11:15 AM EST at 2nd Floor: Sutton Center/South

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-19-155-L01-P
Activity Type: An Application-Based Activity


Speakers
  • Emily K. McCoy, Pharm.D., BCACPModerator: Emily K. McCoy, Pharm.D., BCACP
    Associate Clinical Professor, Auburn University Harrison School of Pharmacy, Mobile, Alabama
      View Biography

Tip of the CAP: Managing Community-Acquired Pneumonia in 2019
9:45 AM

Speakers
  • Emily L. Heil, Pharm.D., BCPS-AQ IDSpeaker: Emily L. Heil, Pharm.D., BCPS-AQ ID
    Associate Professor, University of Maryland School of Pharmacy, Baltimore, Maryland
      View Biography


Learning Objectives
1. Identify key changes in the management of community-acquired pneumonia (CAP) following publication of recent guidelines.
2. Discuss the role of corticosteroids in the management of moderate and severe CAP.
3. Determine appropriate empiric therapy for patients presenting with CAP based on patient- and institution-specific factors.
Time is Brain: Updates in Stroke Management
10:10 AM

Speakers
  • Karen  Berger, Pharm.D., BCPS, BCCCPSpeaker: Karen Berger, Pharm.D., BCPS, BCCCP
    Neurocritical Care Clinical Pharmacist, New York Presbyterian Hospital - Weill Cornell Medical Center, New York, New York
      View Biography


Learning Objectives
1. Identify key changes and controversies in the management of ischemic stroke following publication of recent guidelines.
2. Evaluate the potential place in therapy of tenecteplase in the management of ischemic stroke.
3. Discuss the pharmacist’s role in post-stroke care.
Don’t Go Breakin’ My Heart: Updates, Controversies, and Clinical Considerations in Heart Failure Management
10:35 AM

Speakers
  • Robert J. DiDomenico, Jr., Pharm.D., FCCP, FACC, FHFSA, BCPS-AQ CardiologySpeaker: Robert J. DiDomenico, Jr., Pharm.D., FCCP, FACC, FHFSA, BCPS-AQ Cardiology
    Associate Professor, University of Illinois at Chicago, Chicago, Illinois
      View Biography


Learning Objectives
1. Identify key changes in the management of heart failure following publication of recent guidelines.
2. Evaluate risks versus benefits of cessation of medical therapy in patients with heart failure with recovered ejection fraction.
3. Discuss management considerations for patients with heart failure with preserved ejection fraction and heart failure with mid-range ejection fraction.
4. Discuss the pharmacist’s role after hospital discharge for a patient with heart failure.
Question and Answer
11:00 AM